HP and inflammatory bowel disease: As a matter of fact, we did not observe a variation in serum zonulin during the first 10 weeks of biologic treatment, even in responder patients; further studies are warranted to assess the possibility of restoring intestinal barrier functionality in patients with IBD in long-term remission.